4808 Results

People

  1. Travis
    Travis
  2. Berger
    Berger
  3. Hudis
    Hudis
  4. Ladanyi
    Ladanyi
  5. Arcila
    Arcila
  6. Reis-Filho
    Reis-Filho
  7. Weigelt
    Weigelt
  8. Giralt
    Giralt
  9. Levine
    Levine
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)
  7. Department of Pathology and Laboratory Medicine (714)
  8. Hematologic Malignancies, Division of (683)
  9. Population Sciences Research Program (601)
  10. Sloan Kettering Institute Faculty (586)
  1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRAF mutations in patients with well-differentiated pancreatic neuroendocrine tumors (WD pNETs)
    Meeting Abstract

    Raj, N. P.; Meyers, P. A.; Saltz, L.; Reidy, D. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes after chemoradiation alone for adenocarcinoma of the esophagus and gastroesophageal junction
    Meeting Abstract

    Pham, A.; Goodman, K. A.; Ilson, D. H.; Janjigian, Y. Y.; Ku, G. Y.; Rizk, N. P.; Wu, A. J. C.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • KRAS mutation in colorectal cancer and its association with a stromal-derived gene signature
    Meeting Abstract

    Pelossof, R.; Elkabets, M.; Chow, O.S.; Fairchild, L.; Chen, C. T.; Setty, M.; Smith, J. J.; Dow, L. E.; O'Rourke, K. P.; Lowe, S. W.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Preoperative serum VEGF-A levels to predict survival for Caucasian and Asian patients undergoing resection for gastric adenocarcinoma
    Meeting Abstract

    Park, D. J.; Yoon, C.; Ku, G. Y.; Coit, D. G.; Strong, V. E.; Yang, H. K.; Kim, H. H.; Suh, Y. S.; Yoon, S. S.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Final results of phase Ib of anticancer stem cell antibody tarextumab (OMP-59R5, TRXT, anti-Notch 2/3) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) in patients (pts) with untreated metastatic pancreatic cancer (mPC)
    Meeting Abstract

    O'Reilly, E. M.; Smith, L. S.; Bendell, J. C.; Strickler, J. H.; Zalupski, M.; Gluck, W.; Kapoun, A.; Yen, W. C.; Xu, L.; Hill, D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
    Meeting Abstract

    Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Loss of human epidermal growth factor receptor 2 (HER2) expression in HER2-overexpressing esophagogastric (EG) tumors treated with trastuzumab
    Meeting Abstract

    Janjigian, Y. Y.; Riches, J. C.; Ku, G. Y.; Imtiaz, T.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Boyar, M. S.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Imtiaz, T.; Berger, M. F.; Vakiani, E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy (IMRT) in patients with locally advanced pancreatic cancer (LAPC)
    Meeting Abstract

    Hajj, C.; Huguet, F.; Wu, A. J. C.; O'Reilly, E. M.; Winston, C.; Reidy, D. L.; Allen, P. J.; Goodman, K. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Overall survival and clinical characteristics in BRCA mutation carriers with stage I/II pancreatic cancer (PC)
    Meeting Abstract

    Golan, T.; Sella, T.; Javle, M. M.; Borgida, A.; O'Reilly, E. M.; Kelsen, D. P.; Epelbaum, R.; Kindler, H. L.; Katz, M. H. G.; Gallinger, S.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save